Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions

NCT03912428 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT03912428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 1
Overall status
Terminated
Start date
June 14, 2019
Completion date
June 14, 2024
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, inflammatory, myositis, rheumatoid arthritis